Atlas Trials

Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast Cancer

Clinical trial NCT01262274 · TERMINATED

Trial details

NCT number
NCT01262274
Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Neoplasms
Start date
2010-12-01
Primary completion
2013-06-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.